Genfit S.A. (GNFT.PA)

EUR 3.5

(2.04%)

Total Liabilities Summary of Genfit S.A.

  • Genfit S.A.'s latest annual total liabilities in 2023 was 105.92 Million EUR , down -12.47% from previous year.
  • Genfit S.A.'s latest quarterly total liabilities in 2024 Q2 was 97.41 Million EUR , down 0.0% from previous quarter.
  • Genfit S.A. reported annual total liabilities of 121.01 Million EUR in 2022, down -25.59% from previous year.
  • Genfit S.A. reported annual total liabilities of 162.62 Million EUR in 2021, down -24.28% from previous year.
  • Genfit S.A. reported quarterly total liabilities of 105.92 Million EUR for 2023 FY, down -12.47% from previous quarter.
  • Genfit S.A. reported quarterly total liabilities of 119.38 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Genfit S.A. (2023 - 2005)

Historical Annual Total Liabilities of Genfit S.A. (2023 - 2005)

Year Total Liabilities Total Liabilities Growth
2023 105.92 Million EUR -12.47%
2022 121.01 Million EUR -25.59%
2021 162.62 Million EUR -24.28%
2020 214.77 Million EUR -4.88%
2019 225.78 Million EUR 8.27%
2018 208.53 Million EUR 10.36%
2017 188.95 Million EUR 706.91%
2016 23.41 Million EUR 69.17%
2015 13.84 Million EUR -13.15%
2014 15.93 Million EUR 5.84%
2013 15.05 Million EUR -10.09%
2012 16.74 Million EUR -31.97%
2011 24.61 Million EUR 7.05%
2010 22.99 Million EUR 0.39%
2009 22.9 Million EUR -2.98%
2008 23.61 Million EUR 59.04%
2007 14.84 Million EUR -19.64%
2006 18.47 Million EUR 5.88%
2005 17.44 Million EUR 0.0%

Peer Total Liabilities Comparison of Genfit S.A.

Name Total Liabilities Total Liabilities Difference
ABIONYX Pharma SA 6.91 Million EUR -1432.422%
ABIVAX Société Anonyme 131.05 Million EUR 19.176%
Adocia SA 31.87 Million EUR -232.353%
Aelis Farma SA 13.08 Million EUR -709.794%
Biophytis S.A. 15.84 Million EUR -568.313%
Advicenne S.A. 24.37 Million EUR -334.512%
genOway Société anonyme 14.45 Million EUR -632.535%
IntegraGen SA 5.97 Million EUR -1671.314%
Medesis Pharma S.A. 6.42 Million EUR -1548.272%
Neovacs S.A. 3.71 Million EUR -2753.38%
NFL Biosciences SA 3.62 Million EUR -2825.443%
Plant Advanced Technologies SA 6.78 Million EUR -1461.715%
Quantum Genomics Société Anonyme 3.31 Million EUR -3099.927%
Sensorion SA 13.22 Million EUR -700.778%
Theranexus Société Anonyme 5.01 Million EUR -2011.583%
TME Pharma N.V. 2.78 Million EUR -3703.268%
Valbiotis SA 13.7 Million EUR -672.695%
TheraVet SA 1.48 Million EUR -7032.761%
Valerio Therapeutics Société anonyme 20.46 Million EUR -417.496%
argenx SE 402.79 Million EUR 73.704%
BioSenic S.A. 32.26 Million EUR -228.295%
Celyad Oncology SA 9.97 Million EUR -961.545%
DBV Technologies S.A. 38.74 Million USD -173.378%
Galapagos NV 1.56 Billion EUR 93.218%
GeNeuro SA 20.13 Million EUR -425.926%
Hyloris Pharmaceuticals SA 8.61 Million EUR -1129.923%
Innate Pharma S.A. 132.29 Million EUR 19.934%
Inventiva S.A. 101.59 Million EUR -4.26%
MaaT Pharma SA 22.46 Million EUR -371.493%
MedinCell S.A. 77.77 Million EUR -36.198%
Nanobiotix S.A. 95.74 Million EUR -10.634%
Onward Medical N.V. 25.69 Million EUR -312.176%
Oryzon Genomics S.A. 25.12 Million EUR -321.568%
OSE Immunotherapeutics SA 59.07 Million EUR -79.287%
Oxurion NV 19.73 Million EUR -436.689%
Pharming Group N.V. 228.28 Million EUR 53.601%
Poxel S.A. 53.9 Million EUR -96.51%
GenSight Biologics S.A. 34.72 Million EUR -205.011%
Transgene SA 26.51 Million EUR -299.446%
Financière de Tubize SA 123.65 Million EUR 14.338%
UCB SA 6.56 Billion EUR 98.386%
Valneva SE 341.14 Million EUR 68.951%
Vivoryon Therapeutics N.V. 4.54 Million EUR -2229.47%